
Hepatoblastoma is a sporadic liver cancer that mainly affects children aged one to three. Surgeons may be able to treat hepatoblastoma if it is detected, while liver cancer tumours are small enough to be entirely removed during surgery.
Timely treatment of hepatoblastoma, a rare liver cancer that mainly affects youngsters, is critical for improving survival rates. Early detection and timely management considerably improve the chances of successfully managing the condition and preventing its spread.
If treated early, the tumour can be surgically removed, and chemotherapy can be used to target any leftover cancer cells, lowering the risk of recurrence.
Delaying therapy can allow the cancer to develop, making it more difficult to cure and decreasing the likelihood of complete recovery. Timely therapy also increases overall survival rates and improves the quality of life for affected youngsters.
Common symptoms include:
Causes
Children are more likely to get hepatoblastoma if they:
Risk Factors
Risk factors include:
Complications
Hepatoblastoma is a rare cancer, and while there are no sure ways to prevent it, certain precautions may minimise risk factors or aid in early discovery. Here are some preventative tips:
They may combine surgery with the following treatments:
Chemotherapy: Providers may use chemotherapy to shrink tumours before surgery. Chemotherapy may be systemic or local.
Cost Start From USD 7420 - USD 30000Explore Options
Transarterial chemoembolisation (TACE): Providers inject anti-cancer drugs into one of the arteries that supply blood to your child’s liver. Then, they inject a substance to block the artery.
Radiation therapy: Providers may use radiation therapy after surgery to remove any remaining cancer cells or as an alternative way to treat tumours that surgery can’t remove.
Ablation therapy: This treatment destroys or removes tissue. Providers use ablation therapy to treat recurring hepatoblastoma.
Liver transplantation: Your child’s surgeon may recommend a liver transplant if tumours in your child’s liver are too large to remove with surgery.
Cost Start From USD 45000 - USD 60000Explore Options
The tests include:
Rehabilitation following hepatoblastoma treatment is an essential part of the recovery process. It promotes a child's physical, emotional, and social well-being. The following are some rehabilitation alternatives for children recovering from hepatoblastoma:
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Istanbul, Turkey
Medicana Camlica Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Istanbul, Turkey
Memorial Sisli Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Istanbul, Turkey
Architecture of the Hospital designed as per the comfort of patients-
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Turkey:
The prognosis is determined by factors such as tumour size and spread, early detection, and the child's response to treatment. Survival rates are reasonable when treatment is administered on time and appropriately, particularly for circumscribed malignancies.
In Turkey, hepatoblastoma is mainly diagnosed in children under five years old. Early identification and a comprehensive treatment approach dramatically improve survival rates.
Chemotherapy is often used to diminish tumor growth, followed by surgical procedures such as partial hepatectomy or, in the case of unrespectable tumors, liver transplantation.
These therapies have significantly improved survival rates for pediatric hepatoblastoma patients in Turkey.
While hepatoblastoma can recur after initial treatment, the risks of recurrence are reduced with effective surgery and chemotherapy. Regular follow-up treatment is necessary for the early detection of recurrence.
Family support is critical in treating children with hepatoblastoma. Emotional and psychological support and financial and logistical assistance can significantly improve the child's treatment outcomes. Support organisations and networks in Turkey can also provide aid and comfort.
Yes, Turkey has dedicated hepatoblastoma treatment centers, particularly in major hospitals with pediatric cancer departments. These centers provide comprehensive care, such as advanced chemotherapy, surgical resection, and liver transplantation. They use a comprehensive approach to guarantee that patients receive tailored treatment plans and the best possible outcomes for this rare and challenging condition.